Largest market shown
Germany
$189.2B calculated opportunity across 65 screened products.
Regional export playbook
Chile in Europe
where to look next
Compare buyer markets, access conditions, and product opportunities across Europe. Use this guide to prioritize research, not to treat calculated indicators as guaranteed sales.
3-year opportunity$753.8BCalculated addressable value
Buyer markets25Markets with qualifying rows
FTA markets22Reported access indicator
Avg. distance11,830 kmAverage reported distance
Avg. entry days11Business entry indicator
Europe regional view
Should Chile focus here?
The answer depends on demand, product fit, access, competition, and route economics. This playbook shows where the available trade signals are strongest.
Regional footprint
25 buyer markets
Reported trade and access indicators are available for the qualifying markets shown below.
How to use the guide
Compare demand with access
Start with the strongest markets, then validate buyers, tariffs, standards, logistics, and competition at product level.
Market comparison
Which markets deserve a closer look?
Markets are ranked by calculated three-year opportunity across the qualifying products in this regional view.
| Market | Opportunity | Products | FTA | Distance | Entry days | Top product |
|---|---|---|---|---|---|---|
| GermanyDEU | $189.2B | 65 | Reported | 12,098 km | 8 | Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) |
| United KingdomGBR | $108.0B | 28 | Reported | 11,685 km | 5 | Metals: gold, non-monetary, unwrought (but not powder) |
| NetherlandsNLD | $99.4B | 23 | Reported | 12,027 km | 4 | Oils: petroleum oils and oils obtained from bituminous minerals, crude |
| Switzerland, LiechtensteinCHE | $83.7B | 13 | Reported | 11,866 km | 10 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| FranceFRA | $52.3B | 21 | Reported | 11,663 km | 4 | Aircraft and spacecraft: parts of aeroplanes or helicopters n.e.c. in heading no. 8803 |
| BelgiumBEL | $39.9B | 10 | Reported | 11,905 km | 5 | Product not reported |
| ItalyITA | $27.9B | 12 | Reported | 11,924 km | 11 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| RussiaRUS | $25.9B | 8 | Not reported | 14,153 km | 10 | Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc |
| SpainESP | $25.3B | 13 | Reported | 10,715 km | 13 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| PolandPOL | $24.0B | 13 | Reported | 13,002 km | 37 | Telephones for cellular networks or for other wireless networks |
| CzechiaCZE | $19.5B | 9 | Reported | 12,487 km | 25 | Telephones for cellular networks or for other wireless networks |
| IrelandIRL | $13.1B | 4 | Reported | 11,482 km | 11 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| SloveniaSVN | $11.1B | 2 | Reported | 12,288 km | 8 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale |
| AustriaAUT | $8.5B | 5 | Reported | 12,522 km | 21 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractions |
| HungaryHUN | $4.9B | 2 | Reported | 12,670 km | 7 | Aeroplanes and other aircraft: of an unladen weight exceeding 15,000kg |
| MaltaMLT | $4.2B | 1 | Reported | 11,741 km | 21 | Vessels: n.e.s. in heading no. 8901, for the transport of goods and other vessels for the transport of both persons and goods |
| SlovakiaSVK | $3.6B | 2 | Reported | 12,573 km | 22 | Telephones for cellular networks or for other wireless networks |
| DenmarkDNK | $2.4B | 2 | Reported | 12,645 km | 4 | Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale |
| RomaniaROU | $2.4B | 1 | Not reported | 0 km | 0 | Vehicles: parts, gear boxes |
| SwedenSWE | $2.4B | 2 | Reported | 13,104 km | 8 | Product not reported |
| NorwayNOR | $1.5B | 1 | Reported | 12,747 km | 4 | Product not reported |
| UkraineUKR | $1.4B | 1 | Not reported | 13,566 km | 7 | Product not reported |
| GreeceGRC | $1.1B | 1 | Reported | 12,573 km | 4 | Product not reported |
| CroatiaHRV | $1.0B | 1 | Reported | 12,376 km | 20 | Product not reported |
| LuxembourgLUX | $1.0B | 1 | Reported | 11,940 km | 17 | Product not reported |
Top regional opportunities
Products and markets to review
The rows below are screened by reported buyer demand, exporter position, and available history. Calculated opportunity is a research signal, not a forecast.
| Rank | Market | Product | Opportunity | Buyer growth | Current share |
|---|---|---|---|---|---|
| 1 | Switzerland, LiechtensteinCHE | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $27.7B | +12.3% | +0.0% |
| 2 | United KingdomGBR | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $26.2B | +15.3% | +0.0% |
| 3 | GermanyDEU | HS 850760Electric accumulators: lithium-ion, including separators, whether or not rectangular (including square) | $19.8B | +19.2% | +0.0% |
| 4 | NetherlandsNLD | HS 270900Oils: petroleum oils and oils obtained from bituminous minerals, crude | $18.5B | +6.5% | +0.0% |
| 5 | Switzerland, LiechtensteinCHE | HS 710813Metals: gold, semi-manufactured | $17.2B | +14.3% | +0.0% |
| 6 | GermanyDEU | HS 271121Petroleum gases and other gaseous hydrocarbons: in gaseous state, natural gas | $16.4B | +4.2% | +0.0% |
| 7 | Switzerland, LiechtensteinCHE | HS 710812Metals: gold, non-monetary, unwrought (but not powder) | $16.2B | +12.8% | +0.9% |
| 8 | BelgiumBEL | HS 271019Product description unavailable | $12.8B | +9.1% | +0.0% |
| 9 | GermanyDEU | HS 271019Product description unavailable | $12.3B | +5.8% | +0.1% |
| 10 | RussiaRUS | HS 870323Vehicles: spark-ignition internal combustion reciprocating piston engine, cylinder capacity exceeding 1500cc but not exceeding 3000cc | $12.3B | +12.7% | +0.0% |
| 11 | NetherlandsNLD | HS 271019Product description unavailable | $11.9B | +12.2% | +0.0% |
| 12 | United KingdomGBR | HS 870380Vehicles: with only electric motor for propulsion | $10.2B | +40.0% | +0.0% |
| 13 | SloveniaSVN | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $9.7B | +17.9% | +0.0% |
| 14 | GermanyDEU | HS 851712Telephones for cellular networks or for other wireless networks | $9.7B | +9.2% | +0.0% |
| 15 | GermanyDEU | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $8.4B | +3.5% | +0.0% |
| 16 | BelgiumBEL | HS 300220Vaccines: for human medicine | $8.0B | +20.4% | +0.0% |
| 17 | NetherlandsNLD | HS 847130Data processing machines: portable, digital and automatic, weighing not more than 10kg, consisting of at least a central processing unit, a keyboard and a display | $7.3B | +4.0% | +0.0% |
| 18 | BelgiumBEL | HS 300490Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | $7.0B | +8.9% | +0.0% |
| 19 | United KingdomGBR | HS 851712Telephones for cellular networks or for other wireless networks | $6.7B | +7.5% | +0.0% |
| 20 | GermanyDEU | HS 851762Communication apparatus (excluding telephone sets or base stations): machines for the reception, conversion and transmission or regeneration of voice, images or other data, including switching and routing apparatus | $6.0B | +11.4% | +0.0% |
Sector opportunities
Which product families lead?
HS2 groups make it easier to compare broad product families before moving to individual HS6 products.
HS2 85
HS2 sector 85
48 screened products with $234.6B of reported buyer imports.
$141.9BCalculated opportunity · +11.4% average growthHS2 30
HS2 sector 30
33 screened products with $281.7B of reported buyer imports.
$131.9BCalculated opportunity · +10.0% average growthHS2 87
HS2 sector 87
38 screened products with $206.8B of reported buyer imports.
$89.0BCalculated opportunity · +8.9% average growthHS2 00
HS2 sector 00
22 screened products with $192.3B of reported buyer imports.
$82.3BCalculated opportunity · +8.2% average growthHS2 71
HS2 sector 71
12 screened products with $222.9B of reported buyer imports.
$81.4BCalculated opportunity · +9.8% average growthHS2 84
HS2 sector 84
26 screened products with $118.1B of reported buyer imports.
$75.6BCalculated opportunity · +7.4% average growthHS2 27
HS2 sector 27
3 screened products with $72.4B of reported buyer imports.
$37.0BCalculated opportunity · +5.5% average growthHS2 88
HS2 sector 88
10 screened products with $60.3B of reported buyer imports.
$34.4BCalculated opportunity · +9.5% average growthFrequently asked questions
Using the Europe export playbook
Practical guidance for interpreting regional market and product comparisons.
Should Chile focus on this region?
Use the market ranking as a starting point, then check product fit, buyer requirements, route costs, tariffs, standards, and competitive conditions.
What does calculated opportunity mean?
It is a screening indicator built from demand and exporter-position signals. It is not a confirmed order, sales forecast, or guarantee of market entry.
How should exporters use this page?
Prioritize one market and product combination, then validate buyers, compliance, logistics, pricing, and continuity before making a commercial decision.
Data source
OECD trade statistics with CEPII context
OECD (2025), Balanced international merchandise trade statistics (BIMTS) - HS2017-6D, OECD Data Explorer (accessed on 2026-08-30). OECD BIMTS is the primary trade series for this view. Supporting bilateral trade context uses CEPII BACI bilateral trade flows (202601) under Etalab 2.0 Open Licence. Yugalinks presents derived views of reported observations and calculated indicators. Data terms: OECD Terms & Conditions.